93 filings
Page 4 of 5
8-K
c33cyx 6925
4 Jan 18
Unregistered Sales of Equity Securities
12:00am
8-K
c6umf 325cafr8
20 Dec 17
Other Events
12:00am
8-K
fli7pwc67 xbcu
18 Dec 17
Other Events
12:00am
8-K
mbo dajgvkodl91gh0o
13 Dec 17
Creative Medical Technology Holdings Recruits Top Urologists for CaverstemTM Stem Cell Treatment of Erectile Dysfunction
12:00am
8-K
pse4szftu2m3dukmn
17 Nov 17
Entry into a Material Definitive Agreement
12:00am
8-K
kjawgg3dahj17j0ld98
16 Nov 17
Entry into a Material Definitive Agreement
12:00am
8-K
3uefe147z98aj
18 Oct 17
Trial Results Support Initiation of Urologist Outreach and Commercialization
12:00am
8-K
aheccqv cgy
12 Oct 17
Creative Medical Technology Holdings Expands Personalized Minimally Manipulated Stem Cell
12:00am
8-K
ig7j4w
28 Aug 17
Creative Medical Technology Holdings Achieves 100% Patient Enrollment in CaverstemTM Clinical Trial for Stem Cell Treatment of Erectile Dysfunction
12:00am
8-K
cv3jp6gbo4l5m
25 Jul 17
Creative Medical Technology Holdings Demonstrates AmnioStem Derived Exosomes Inhibit Glioma Growth
12:00am
8-K
s2yw5hh4dzd
21 Jun 17
Other Events
12:00am
8-K
l8ucfurte
7 Jun 17
Creative Medical Technology Holdings Develops Platform Aimed at Augmenting All Mesenchymal Stem Cell Therapies for Lower Back Pain
12:00am
8-K
fu4cj7 6jm
24 May 17
Other Events
12:00am
8-K
2cdi78p4vbh3qqyv6l5z
18 May 17
Creative Medical Technology Holdings to Expand into 10 Billion Dollar per Year Lower Back Pain Market with Acquisition of Issued US Stem Cell Patent
12:00am
8-K
rsxsy7g9gtvi
4 Apr 17
Creative Medical Technology Holdings Files Patent on Reducing Radiation Toxicity Using AmnioStem Universal Donor Stem Cell Product
12:00am
8-K
qqd46 v84z
8 Mar 17
Creative Medical Technology Holdings Appoints Internationally Renowned Stem Cell Pioneer as Chief Scientific Officer
12:00am
8-K
32fd kzqyy0bmjsj5uel
22 Feb 17
Creative Medical Technology Holdings Announces Initiation of In House Research Program at San Diego BioLabs
12:00am
8-K
ina0wwd
13 Dec 16
Other Events
12:00am
8-K
3soem
6 Dec 16
Clinical Stage Stem Cell Therapeutics Company Aims to Develop “Universal Donor” Stem Cell “Drug” for Stroke Patients
12:00am
8-K
t2h7e15ysb2m7vn
16 Nov 16
Creative Medical Technology Holdings Announces Creation of Amniotic Fluid Stem Cell Focused Subsidiary AmnioStem LLC
12:00am